PEAK6 Group’s Usana Health Sciences USNA Stock Holding History

PEAK6 Group’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$6K	–	5062
2017 Q2	$6K	Buy	+100	New	+$6.16K	﹤0.01%	4412

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PEAK6 Group's USNA Position: Q1 2018 in Review

PEAK6 Group sold out of Usana Health Sciences (USNA) in Q1 2018, closing a stake of 8,878 shares — an estimated $657K sold.

PEAK6 Group first reported a position in USNA in Q2 2013 and held it in 3 quarters. The position peaked at $657K in Q4 2017. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

PEAK6 Group reported no remaining Usana Health Sciences position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 8,878 Usana Health Sciences shares in Q1 2018, an estimated $657K.
PEAK6 Group first reported a position in Usana Health Sciences in Q2 2013 and held it in 3 quarters.
PEAK6 Group's Usana Health Sciences position peaked at $657K in Q4 2017.
168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.